Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $100.0550 (-0.93%) ($98.7800 - $102.8900) on Thu. Sep. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.46% (three month average) | RSI | 18 | Latest Price | $100.0550(-0.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.6% a day on average for past five trading days. | Weekly Trend | LGND declines -4.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(54%) IWO(52%) XBI(49%) IWM(48%) IWC(47%) | Factors Impacting LGND price | LGND will decline at least -1.23% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-15%) IGOV(-7%) UNG(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.23% (StdDev 2.46%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $90.75(-9.3%) | Inflection Point | Yes | Resistance Level | $106.29 | 5 Day Moving Average | $99.6(0.46%) | 10 Day Moving Average | $101.08(-1.01%) | 20 Day Moving Average | $106.29(-5.87%) | To recent high | -21% | To recent low | 1.2% | Market Cap | $1.608b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |